How Biotechs Survive the Valley of Death
I AM BIO
English - October 17, 2023 09:00 - 25 minutes - 23 MB - ★★★★★ - 67 ratingsLife Sciences Science Health & Fitness Medicine coronavirus covid virus biopharmaceuticals biotech patients biotechnology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Biotech Women Striking at the Glass Ceiling
Next Episode: The Synbio Revolution is Here
Follow us on LinkedIn, X, Facebook and Instagram.
Visit us at https://www.bio.org/
For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it’s like to struggle and survive in this rough-and-tumble industry.